Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ESCITALOPRAM
- Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
- Pattern Separation in Major Depressive Disorder
- MBCT and Escitalopram for Treatment-Resistant Depression in Older Adults
- The Effect of SSRIs on Threat of Shock Potentiated Neural Circuitry
- Efficacy of Dextromethorphan-Bupropion Versus SSRIs in the Treatment of Major Depressive Disorder
- Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole
- Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
- Neuroimaging of Escitalopram in Autism Spectrum Disorder
- RCT Study on the Therapeutic Effect of Escitalopram Loaded With XingpiJieyu Formula on Resting State EEG Energy Abnormalities in Severe Liver Depression and Spleen Deficiency Type MDD
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
- Effort and Antidepressant Study Test
- Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients with Major Depressive Disorder
- A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets
- Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People
- Comparative Efficacy of Escitalopram Monotherapy and Escitalopram in Adjuvant With Pizotifen in Depressive Disorder
- A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET
- Sequential Multiple Assignment Randomized Trial for Bipolar Depression
- Improvement of Depression With Use of ATP
- Escitalopram in Asthma Patients With Frequent Exacerbation
- Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSD
- Psychopharmacotherapy for Depressive Patients
- The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
- Development and Application of Comprehensive Intervention Techniques for Adolescent Depression
- A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression
- The Effect of Escitalopram in PCOS
- Effect of Electroacupuncture on Treating the First-episode Depression
- Influence of Oxycodone on Individuals Taking an SSRI
- Effects of Paroxetine on Cardiovascular Function in Septic Patients
- Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer
- Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
- A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems
- Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
- Home Transcutaneous Electrical Acustimulation (TEA)
- Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis
- Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation
- Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia
- Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
- A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment
- Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
- Aβ Dynamics in LLMD
- Treatment Interrupts Depression Early
- Adjunctive Game Intervention for Anhedonia in MDD Patients
- Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer
- Enhancing Processing Speed and Executive Functioning in Depressed Older Adults With Computerized Cognitive Training
- Mirtazapine in Cancer-related Poly-symptomatology
- Antidepressant Response in Older Adults With Comorbid PTSD and MDD
- Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)
- Partners in Caring for Anxious Youth
- A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder
- Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
- A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
- Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram
- Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
- The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms
- Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression
- A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression
- Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
- Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
- Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy Volunteers
- Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
- Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity
- Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study
- The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive Depression
- The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.
- Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory Symptoms
- Effects of Escitalopram on the Sleep EEG Power in Patients With Major Depressive Disorder
- Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression
- Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) Treatment
- A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
- Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects
- Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (TECAS).
- Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive Disorder
- Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.
- A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression
- Escitalopram and Language Intervention for Subacute Aphasia
- Contact: Developing New Clinical Management Strategies
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
- A Study Utilizing Escitalopram in Glioma Patients
- Antidepressants Trial in Parkinson's Disease
- A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression
- Modafinil's Effects on Cognition in Remitted MDD
- Biomarkers of Antidepressant Response and Suicidal Events in Depressed Youth
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
- Impact of Escitalopram on Sperm DNA Fragmentation
- Anxiety and Depression in Epilepsy: A Pilot Treatment Study
- Treatments for Anxiety: Meditation and Escitalopram
- Comparative Efficacy of Duloxetine vs Escitalopram in Patients With Fibromyalgia
- Anxiety and Depression in Epilepsy: A Treatment Study
- OxSYPan: Oxford Study With Young People on Antidepressants
- Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
- Adherence to Antidepressant Treatment in Subjects With Depression
- Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety
- Chinese Herb for the Treatment of Depression and Anxiety Disorders
- Treating Hearing Loss to Improve Mood and Cognition in Older Adults
- Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders
- A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol
- Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression
- Cognitive Dysfunction in MDD Patients
- Serotonin and Motor Plasticity
- A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward System
- Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD
- Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)
- Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
- Escitalopram for Agitation in Alzheimer's Disease
- Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer
- Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Treatment Outcome in Major Depressive Disorder
- Cortical Ischemic Stroke and Serotonin
- A Trial of Dextromethorphan for Treatment of Major Depressive Disorder
- Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety
- Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators
- Enhancement of Learning Associated Neural Plasticity by Selective Serotonin Reuptake Inhibitors
- Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)
- Study of Neural Responses Induced by Antidepressant Effects
- The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
- Advancing Personalized Antidepressant Treatment Using PET/MRI
- SSRI Effects on Depression and Immunity in HIV/AIDS
- Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth
- Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode
- A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
- The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment Depression
- Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment
- Effectiveness and Safety of Electro-acupuncture for Mild-to-moderate Perimenopausal Depression
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
- The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)
- Pharmacovigilance in Gerontopsychiatric Patients
- Connectivity Affecting the Antidepressant REsponse Study
- Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury
- The Gut Microbiota in Obsessive-Compulsive Disorder
- Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder
- Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress
- Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
- Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder
- Study of Drug Combination on Pharmacokinetics in Healthy Volunteers
- Escitalopram Effects on CSF Amyloid Beta
- SSRI Study for Functional Dyspepsia (SS)
- The ISLAND Study: InSuLa Assessed Needs for Depression
- A Clinical Trial to Investigate the Pharmacokinetics and the Effect on ECG of Escitalopram in Elderly Volunteers
- Developing New Clinical Management Strategies
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed Condition
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting Condition
- Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
- The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS
- Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
- Mechanisms of Antidepressant Non-Response in Late-Life Depression
- Brain Aging and Treatment Response in Geriatric Depression
- Interpersonal Psychotherapy for Treatment Resistant Depression
- Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
- Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment
- Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs
- A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom
- Interaction Between Paroxetine and Telaprevir
- Escitalopram for the Treatment of Depression in Alzheimer's Disease
- An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms
- A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
- A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women
- Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
- Serotonergic Modulation of Motor Function in Subacute and Chronic SCI
- Algorithm Guided Treatment Strategies for Major Depressive Disorder
- Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI)
- Enhanced Motor Recovery Using Serotonergic Agents in Stroke
- Bioequivalence Study of Escitalopram Tablets 10 mg
- Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
- Emotional and Cognitive Control in Late-Onset Depression
- Ketamine in the Treatment of Suicidal Depression
- Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress Disorder
- Combination Treatment Study for Memory Impairment and Depression
- Canadian Biomarker Integration Network for Depression Study
- Fludrocortisone and Information Processing in Healthy Volunteers
- A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram
- Sequence Towards Remission in Depression
- Modafinil - Escitalopram Study for Cocaine Dependence
- Lexapro®'s Efficacy After Dose Escalation in Remission Study
- The Effects of Escitalopram on Cytokines
- An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder
- Escitalopram Treatment In Acute Stroke
- Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder
- Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder
- Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord Injury
- Escitalopram in the Treatment of Postpartum Depression
- Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
- Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)
- Bipolar Depression and Inflammation
- Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders
- Analgesic Effect of Escitalopram in Total Knee Arthroplasty (TKA)
- Exploring Biomarkers for Depression
- A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy Volunteers
- Predicting Medication Response in Obsessive Compulsive Disorder
- Influence of Escitalopram on Fear Conditioning
- Bioequivalence Study Comparing Two Formulations of Escitalopram
- Electroencephalography (EEG) Signal Processing
- Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
- Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
- Investigation of Tibolone and Escitalopram in Perimenopausal Depression
- Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction
- The Quietude Study: Quetiapine Use for Agitated Depression
- Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
- Antidepressant Treatment at an Inner City Asthma Clinic
- Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder
- The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
- Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder
- Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response
- Lexapro for Major Depression in Patients With Epilepsy
- EScitalopram PIndolol ONset of Action
- Circadian Effects of Escitalopram
- Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
- Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder
- To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder (MDD)
- Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone
- Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder (MDD)
- Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
- Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
- Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
- Neural Responses and Dysphoria: Modulation by a Pharmacological Probe
- TMC435-TiDP16-C112 - Interaction Trial With Antidepressants
- Biomarkers for Outcomes In Late-life Depression (BOLD)
- Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype
- A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers
- A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder
- Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder
- AZD7268 Safety and Tolerability Study
- Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder
- The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)
- A Study of Patients With Major Depressive Disorder and Residual Apathy
- Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth Weight
- Effects on Clinical and Functional Outcome of Escitalopram in Adult Stroke Patients
- Escitalopram (Lexapro) for Depression MS or ALS
- Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
- Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
- Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
- Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed Patients
- Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment
- Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
- VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
- Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression
- Aging Brain Changes, Executive Dysfunction and Depression
- Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)
- Escitalopram in Patients With Generalized Anxiety Disorder
- Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients
- Escitalopram in Patients With Social Anxiety Disorder
- MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women
- Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
- Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit
- A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression
- Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
- Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression
- Escitalopram (Lexapro) for the Treatment of Postpartum Depression
- Omega-3 for Peri- and Postmenopausal Depression
- Brain Effects of Escitalopram and Citalopram Using fMRI
- Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
- An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients
- Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder
- Neurotrophic Factors and Depression
- Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
- Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder
- Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression
- Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD
- Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression
- Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder
- Treatment Response of Geriatric Depression
- Sinusitis and Facial Pain Disorders Anti-Depression Trial
- fMRI Studies of Emotional Brain Circuitry in People With Major Depression
- Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety
- Treatment of Post-traumatic Stress Disorder With High Doses of Escitalopram
- Clinical Neurobiology of Serotonin and Addiction
- Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
- Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder
- Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study
- Treatment Youth With Obsessive-Compulsive Disorder
- Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on Escitalopram
- A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression
- Progression Delaying Effect of Escitalopram in Alzheimer's Disease
- International Study to Predict Optimised Treatment - in Depression
- The Effect of Escitalopram on the Pharmacokinetics and Pharmacodynamics of Tramadol in Healthy Subjects
- Escitalopram in Adult Patients With Major Depressive Disorder
- Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
- Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)
- Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
- Efficacy Study of Escitalopram for Depression in Patients With Diabetes
- Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg
- Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg
- Combination Lexapro and Massage for Treatment of Depression in Older Adults
- Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon
- Escitalopram Treatment of Night Eating Syndrome
- Psychotherapy and Pharmacotherapy in Dissociative Disorders
- Brain Mechanisms and Targeting Insomnia in Major Depression
- Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
- Behavioral Insomnia Therapy For Those With Insomnia and Depression
- Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram
- ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder
- Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features
- Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression
- Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
- Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy
- Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy
- Dementia Antipsychotics And Antidepressants Discontinuation Study
- Combining Medications to Enhance Depression Outcomes
- SAT vs Escitalopram for Rectal Hypersensitivity
- Responses of Myocardial Ischemia to Escitalopram Treatment
- A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression
- Efficacy of Escitalopram in the Treatment of Internet Addiction
- Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene
- Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment
- An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
- Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study
- Does Dual Therapy Hasten Antidepressant Response?
- Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression
- Escitalopram and Depression in Elderly Alzheimer's Patients
- Flushing in Social Anxiety Disorder on Cipralex
- Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
- SSRI and Buprenorphine
- Brain GABA Levels and Treatment Response in Major Depressive Disorder
- Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment
- Escitalopram in Schizophrenia in OCD- Open Label Study
- Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response
- Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment
- Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
- Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder
- Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
- Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder
- Galantamine Augmentation of Escitalopram for Treatment of Depression
- A Study for Participants With Major Depression
- Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder
- PACEPro - Mood Management Pilot
- An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder
- Evaluation of the Effects of Duloxetine on Norepinephrine
- A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women
- Dichotic Listening as a Predictor of Medication Response in Depression
- Pupillary Changes as a Potential Biomarker for Escitalopram in Relation to CYP2C19 Polymorphism
- Antidepressant Safety in Kids Study
- A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder
- Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
- Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major Depression
- Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
- Clinical Pharmacogenomics of Antidepressant Response
- Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication
- Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients
- Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.
- Imaging Predictors of Treatment Response in Depression
- Aripiprazole and Lexapro Drug Interaction Study
- Biological Markers of Response to Treatment in Major Depressive Disorder
- Identifying Factors That Predict Antidepressant Treatment Response
- An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder
- Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
- Functional Neuroimaging in Depression
- Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)
- PTSD Prevention Using Escitalopram
- Memory Functioning and Antidepressant Treatment
- Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)
- Treatment of Depression Following Multiple Brain Tests
- Are Two Antidepressants a Good Initial Treatment for Depression?
- Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro
- Mineralocorticoid Receptor in the Treatment of Severe Depression
- Lexapro in the Treatment of Patients With Postpartum Depression
- Treatment Resistant Bipolar Depression
- Escitalopram Treatment of Patients With Agitated Dementia
- Essential Fatty Acids for Major Depression
- DBT and Escitalopram in Borderline Personality Disorder
- Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
- Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder
- Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
- Functional Dyspepsia Treatment Trial
- MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting
- Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder
- Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
- Medications for the Treatment of Dysthymic Disorder and Double Depression
- Investigation of a Combination Treatment of Escitalopram and rTMS
- Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia
- Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia
- Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain
- Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study
- Escitalopram in the Treatment of Dysthymic Disorder, Double Blind
- A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression
- Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)
- Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression
- Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder
- Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
- Depression-Diabetes Mechanisms: Urban African Americans
- The Effects of Increased Central Serotonergic Activity on Information Processing
- Treatment Choices for Improving Adherence and Outcome
- Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension
- Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram
- The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram
- Antidepressant Medication Plus Donepezil for Treating Late-life Depression
- Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression
- Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
- Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients
- Depression, Epinephrine, and Platelet Function
- Escitalopram as a Treatment for Pain in Polyneuropathy
- Escitalopram as a Mood Stabilizer for Bipolar II Disorder
- The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis
- Specific Effects of Escitalopram on Neuroendocrine Response
- Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome
- Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
- The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia
- Prevention of Post Traumatic Stress Disorder by Early Treatment
- DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome
- Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients
- Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
- Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment
- Treatment of Depression in the Elderly
- Study of Escitalopram in the Treatment of Specific Phobia
- Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
- Escitalopram for the Treatment of Self-Injurious Skin Picking
- SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims
- Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
- Study of Escitalopram in Adult Patients With Major Depressive Disorder
- The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder
- Drug Therapy for Generalized Anxiety Disorder Among the Elderly
- Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression
- Lexapro and Pramipexole and to Treat Major Depression
- Treatment of Adolescent Suicide Attempters (TASA)
- Treatment of Depression in Adults
- Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression
- Preventing Post-Stroke Depression
- SAM-e for the Treatment of Depression in Patients With Parkinson's Disease
- An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression
- Effects Of Antidepressants On Sexual Functioning In Adults
- Effects of Antidepressants on Sexual Functioning
Clinical trials list
click for details